OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
RESP55

Resonance Specialties Ltd

Specialty ChemicalsVerified

Resonance Specialties Ltd maintains a strong liquidity position with a current ratio of 6.76, indicating that it holds significantly more current assets than current liabilities. However, the company reported negative operating cash flow of -25,060,000 INR, which raises concerns about its ability to generate cash from operations. Free cash flow, at 65,601,000 INR, remains positive, suggesting that the company is able to fund operations and potentially reinvest in growth. Profitability metrics show that the company is performing well relative to industry norms. Return on equity (ROE) of 10.26% and return on assets (ROA) of 8.69% are both above the industry median for specialty chemicals, indicating efficient use of equity and assets to generate returns. Operating income of 257,290,000 INR and net income of 65,662,000 INR further support the company's profitability. The company's revenue is concentrated in a single business segment, as disclosed in its latest financial report, with no geographic diversification provided in the available data. This lack of diversification may expose the company to regional economic or regulatory risks, though the data does not specify the geographic distribution of its revenue. Looking ahead, the company is expected to maintain a stable growth trajectory, with no significant changes in revenue or operating performance projected in the next fiscal year. Capital expenditures of -15,644,000 INR suggest that the company is not currently investing heavily in new infrastructure or expansion. Risk factors include a medium liquidity risk due to the negative operating cash flow and a low dilution risk, as the company has not issued additional shares recently and has no near-term pressure to do so. The debt-to-equity ratio of 0.05 is low, indicating that the company is not heavily leveraged and has a strong equity base. Recent filings and transcripts do not indicate any major corporate events or strategic shifts in the past quarter. The company has not disclosed any material changes in its business model or product offerings.

30-day price · RESP+37.53 (+41.5%)
Low$88.30High$142.90Close$127.89As of22 May, 00:00 UTC
Profile
CompanyResonance Specialties Ltd
TickerRESP.BO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Resonance Specialties Ltd is a specialty chemicals company that produces and sells chemical products for industrial and commercial applications.

Classification. Resonance Specialties Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Resonance Specialties Ltd maintains a strong liquidity position with a current ratio of 6.76, indicating that it holds significantly more current assets than current liabilities. However, the company reported negative operating cash flow of -25,060,000 INR, which raises concerns about its ability to generate cash from operations. Free cash flow, at 65,601,000 INR, remains positive, suggesting that the company is able to fund operations and potentially reinvest in growth. Profitability metrics show that the company is performing well relative to industry norms. Return on equity (ROE) of 10.26% and return on assets (ROA) of 8.69% are both above the industry median for specialty chemicals, indicating efficient use of equity and assets to generate returns. Operating income of 257,290,000 INR and net income of 65,662,000 INR further support the company's profitability. The company's revenue is concentrated in a single business segment, as disclosed in its latest financial report, with no geographic diversification provided in the available data. This lack of diversification may expose the company to regional economic or regulatory risks, though the data does not specify the geographic distribution of its revenue. Looking ahead, the company is expected to maintain a stable growth trajectory, with no significant changes in revenue or operating performance projected in the next fiscal year. Capital expenditures of -15,644,000 INR suggest that the company is not currently investing heavily in new infrastructure or expansion. Risk factors include a medium liquidity risk due to the negative operating cash flow and a low dilution risk, as the company has not issued additional shares recently and has no near-term pressure to do so. The debt-to-equity ratio of 0.05 is low, indicating that the company is not heavily leveraged and has a strong equity base. Recent filings and transcripts do not indicate any major corporate events or strategic shifts in the past quarter. The company has not disclosed any material changes in its business model or product offerings.
Key takeaways
  • Resonance Specialties Ltd has a strong equity base and low debt, with a debt-to-equity ratio of 0.05.
  • The company generates positive free cash flow despite negative operating cash flow, indicating strong underlying profitability.
  • ROE and ROA are above industry medians, suggesting efficient capital use and strong returns.
  • The company operates in a single business segment with no disclosed geographic diversification, which may increase exposure to regional risks.
  • No significant dilution risk is present, and the company is not currently investing heavily in capital expenditures.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$778.1M
Gross profit$404.9M
Operating income$257.3M
Net income$65.7M
R&D
SG&A
D&A
SBC
Operating cash flow-$25.1M
CapEx-$15.6M
Free cash flow$65.6M
Total assets$755.5M
Total liabilities$115.3M
Total equity$640.2M
Cash & equivalents
Long-term debt$33.1M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$640.2M
Net cash-$33.1M
Current ratio6.8
Debt/Equity0.1
ROA8.7%
ROE10.3%
Cash conversion-38.0%
CapEx/Revenue-2.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricRESPActivity
Op margin33.1%5.5% medp25 -0.0% · p75 10.8%top quartile
Net margin8.4%4.1% medp25 0.1% · p75 8.8%above median
Gross margin52.0%20.5% medp25 12.4% · p75 29.7%top quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-2.0%-6.2% medp25 -13.4% · p75 -2.6%top quartile
Debt / equity5.0%37.1% medp25 10.3% · p75 82.0%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-23 13:25 UTC#fe1bab14
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 04:50 UTCJob: dc626572